These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 19101069)

  • 1. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
    Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
    Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
    Casagrande G; te Kronnie G; Basso G
    Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
    Kuphal F; Behrens J
    Exp Cell Res; 2006 Feb; 312(4):457-67. PubMed ID: 16368435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
    Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
    Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.
    Khan NI; Bradstock KF; Bendall LJ
    Br J Haematol; 2007 Aug; 138(3):338-48. PubMed ID: 17614820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential requirement for beta-catenin in epithelial and fiber cells during lens development.
    Cain S; Martinez G; Kokkinos MI; Turner K; Richardson RJ; Abud HE; Huelsken J; Robinson ML; de Iongh RU
    Dev Biol; 2008 Sep; 321(2):420-33. PubMed ID: 18652817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Childhood acute lymphoblastic leukemia with t(1;19) lacking E2A-pBX1 chimeric transcripts].
    Matsubara K; Hirata T
    Rinsho Ketsueki; 2005 Jan; 46(1):7-12. PubMed ID: 16708911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells.
    Novellino L; De Filippo A; Deho P; Perrone F; Pilotti S; Parmiani G; Castelli C
    Cell Signal; 2008 May; 20(5):872-83. PubMed ID: 18276111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
    Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
    Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Wnt levels in the neural tube impair the function of adherens junctions during neurulation.
    Shariatmadari M; Peyronnet J; Papachristou P; Horn Z; Sousa KM; Arenas E; Ringstedt T
    Mol Cell Neurosci; 2005 Nov; 30(3):437-51. PubMed ID: 16154760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis.
    Døsen G; Tenstad E; Nygren MK; Stubberud H; Funderud S; Rian E
    BMC Immunol; 2006 Jun; 7():13. PubMed ID: 16808837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
    Baudis M; Prima V; Tung YH; Hunger SP
    Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular localization and signaling activity of beta-catenin in migrating neural crest cells.
    de Melker AA; Desban N; Duband JL
    Dev Dyn; 2004 Aug; 230(4):708-26. PubMed ID: 15254905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells.
    Kapitanović S; Cacev T; Antica M; Kralj M; Cavrić G; Pavelić K; Spaventi R
    Exp Mol Pathol; 2006 Feb; 80(1):91-6. PubMed ID: 15963497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.
    Wang K; Ma Q; Ren Y; He J; Zhang Y; Zhang Y; Chen W
    Oncol Rep; 2007 Jan; 17(1):89-96. PubMed ID: 17143483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
    Calvo KR; Knoepfler P; McGrath S; Kamps MP
    Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells.
    Menichella DM; Arroyo EJ; Awatramani R; Xu T; Baron P; Vallat JM; Balsamo J; Lilien J; Scarlato G; Kamholz J; Scherer SS; Shy ME
    Mol Cell Neurosci; 2001 Dec; 18(6):606-18. PubMed ID: 11749037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
    de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
    Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.